Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mouth Diseases | 25 | 2020 | 239 | 7.620 |
Why?
|
Stomatitis | 28 | 2023 | 269 | 5.930 |
Why?
|
Graft vs Host Disease | 35 | 2022 | 2951 | 5.530 |
Why?
|
Mouth Mucosa | 15 | 2021 | 434 | 2.720 |
Why?
|
Hematopoietic Stem Cell Transplantation | 30 | 2023 | 5425 | 2.650 |
Why?
|
Osteonecrosis | 9 | 2011 | 227 | 1.970 |
Why?
|
Oral Medicine | 4 | 2016 | 31 | 1.920 |
Why?
|
Head and Neck Neoplasms | 24 | 2023 | 2712 | 1.830 |
Why?
|
Mucositis | 9 | 2023 | 101 | 1.810 |
Why?
|
Mandibular Diseases | 6 | 2013 | 119 | 1.770 |
Why?
|
Oral Ulcer | 9 | 2021 | 96 | 1.750 |
Why?
|
Diphosphonates | 11 | 2013 | 625 | 1.730 |
Why?
|
Dental Caries | 8 | 2023 | 415 | 1.690 |
Why?
|
Tacrolimus | 7 | 2022 | 741 | 1.470 |
Why?
|
Mouth Neoplasms | 7 | 2024 | 601 | 1.370 |
Why?
|
Lichen Planus, Oral | 7 | 2022 | 53 | 1.330 |
Why?
|
Osteoradionecrosis | 4 | 2022 | 49 | 1.300 |
Why?
|
Bone Density Conservation Agents | 9 | 2012 | 774 | 1.220 |
Why?
|
Mouth | 7 | 2023 | 373 | 1.210 |
Why?
|
Xerostomia | 3 | 2023 | 95 | 1.170 |
Why?
|
Immunosuppressive Agents | 10 | 2020 | 4147 | 1.100 |
Why?
|
Sirolimus | 5 | 2020 | 1562 | 1.050 |
Why?
|
Oral Health | 7 | 2022 | 472 | 0.970 |
Why?
|
Dexamethasone | 4 | 2022 | 1949 | 0.960 |
Why?
|
TOR Serine-Threonine Kinases | 6 | 2014 | 2107 | 0.930 |
Why?
|
Burning Mouth Syndrome | 4 | 2019 | 31 | 0.930 |
Why?
|
Jaw Diseases | 5 | 2011 | 90 | 0.880 |
Why?
|
Stomatitis, Herpetic | 3 | 2015 | 12 | 0.810 |
Why?
|
Diagnosis, Oral | 2 | 2019 | 23 | 0.810 |
Why?
|
Transplantation Conditioning | 5 | 2017 | 1597 | 0.800 |
Why?
|
Chronic Disease | 21 | 2022 | 9144 | 0.790 |
Why?
|
Administration, Topical | 10 | 2022 | 688 | 0.780 |
Why?
|
Trigeminal Neuralgia | 2 | 2021 | 113 | 0.780 |
Why?
|
Salivary Glands | 4 | 2012 | 228 | 0.760 |
Why?
|
Skin Diseases, Vesiculobullous | 2 | 2020 | 85 | 0.730 |
Why?
|
Paresthesia | 3 | 2017 | 162 | 0.680 |
Why?
|
Molar | 1 | 2019 | 152 | 0.640 |
Why?
|
Neoplasms | 20 | 2023 | 21596 | 0.620 |
Why?
|
Carcinoma, Squamous Cell | 7 | 2024 | 4029 | 0.610 |
Why?
|
Hypertonic Solutions | 1 | 2016 | 93 | 0.580 |
Why?
|
Stomatitis, Aphthous | 3 | 2015 | 51 | 0.580 |
Why?
|
Antifungal Agents | 3 | 2019 | 729 | 0.560 |
Why?
|
Keratosis | 2 | 2020 | 81 | 0.550 |
Why?
|
Submandibular Gland | 2 | 2006 | 86 | 0.550 |
Why?
|
Myeloablative Agonists | 1 | 2016 | 218 | 0.540 |
Why?
|
Mandible | 4 | 2021 | 740 | 0.540 |
Why?
|
Calcium Phosphates | 1 | 2016 | 171 | 0.530 |
Why?
|
Facial Transplantation | 2 | 2015 | 226 | 0.520 |
Why?
|
Transplantation, Homologous | 9 | 2023 | 4771 | 0.520 |
Why?
|
Antineoplastic Agents | 12 | 2020 | 13655 | 0.510 |
Why?
|
Humans | 143 | 2024 | 742088 | 0.500 |
Why?
|
Drug Compounding | 1 | 2016 | 242 | 0.500 |
Why?
|
Radiography, Panoramic | 3 | 2010 | 115 | 0.500 |
Why?
|
Fibroblast Growth Factor 7 | 2 | 2015 | 61 | 0.490 |
Why?
|
Neuralgia | 1 | 2021 | 568 | 0.490 |
Why?
|
Bacteremia | 3 | 2017 | 962 | 0.490 |
Why?
|
Ultraviolet Therapy | 1 | 2014 | 81 | 0.480 |
Why?
|
Cheilitis | 1 | 2013 | 8 | 0.480 |
Why?
|
Candidiasis, Oral | 4 | 2020 | 60 | 0.480 |
Why?
|
Tooth | 1 | 2015 | 207 | 0.450 |
Why?
|
Acyclovir | 1 | 2013 | 272 | 0.430 |
Why?
|
Common Variable Immunodeficiency | 1 | 2013 | 93 | 0.430 |
Why?
|
Glucocorticoids | 5 | 2022 | 2107 | 0.430 |
Why?
|
Dental Care for Chronically Ill | 3 | 2017 | 33 | 0.420 |
Why?
|
Focal Infection, Dental | 1 | 2011 | 24 | 0.410 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 664 | 0.410 |
Why?
|
Infarction | 1 | 2013 | 243 | 0.410 |
Why?
|
Immunocompromised Host | 3 | 2013 | 847 | 0.410 |
Why?
|
Oral Hygiene | 3 | 2022 | 125 | 0.410 |
Why?
|
Valine | 1 | 2013 | 413 | 0.400 |
Why?
|
Middle Aged | 61 | 2024 | 213127 | 0.400 |
Why?
|
Tongue Diseases | 2 | 2008 | 67 | 0.380 |
Why?
|
Antiviral Agents | 3 | 2013 | 2978 | 0.380 |
Why?
|
Retrospective Studies | 30 | 2021 | 77098 | 0.380 |
Why?
|
Fatty Alcohols | 1 | 2010 | 23 | 0.370 |
Why?
|
Herpes Labialis | 1 | 2010 | 29 | 0.370 |
Why?
|
Opportunistic Infections | 1 | 2013 | 389 | 0.370 |
Why?
|
Adrenal Cortex Hormones | 4 | 2017 | 1847 | 0.360 |
Why?
|
Male | 78 | 2024 | 349538 | 0.360 |
Why?
|
Adult | 49 | 2022 | 213712 | 0.360 |
Why?
|
Aged | 45 | 2021 | 162944 | 0.350 |
Why?
|
Polyps | 2 | 2008 | 189 | 0.350 |
Why?
|
Stomatognathic Diseases | 2 | 2020 | 21 | 0.340 |
Why?
|
Mandibular Injuries | 1 | 2008 | 19 | 0.330 |
Why?
|
Tooth Loss | 2 | 2023 | 197 | 0.320 |
Why?
|
Saliva | 4 | 2023 | 805 | 0.320 |
Why?
|
Angiomatosis, Bacillary | 1 | 2008 | 4 | 0.320 |
Why?
|
Papillomavirus Infections | 1 | 2020 | 1585 | 0.320 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2130 | 0.320 |
Why?
|
Bartonella Infections | 1 | 2008 | 22 | 0.320 |
Why?
|
Female | 74 | 2024 | 379592 | 0.320 |
Why?
|
Survivors | 3 | 2020 | 2286 | 0.310 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2008 | 63 | 0.310 |
Why?
|
Osseointegration | 1 | 2009 | 276 | 0.300 |
Why?
|
Trigeminal Nerve Diseases | 1 | 2008 | 55 | 0.300 |
Why?
|
Trigeminal Ganglion | 1 | 2008 | 186 | 0.300 |
Why?
|
Testosterone | 4 | 2006 | 2401 | 0.300 |
Why?
|
Antigens, CD | 1 | 2018 | 4024 | 0.300 |
Why?
|
Mandibular Neoplasms | 1 | 2008 | 129 | 0.300 |
Why?
|
Gene Expression Regulation | 7 | 2006 | 12071 | 0.300 |
Why?
|
Clonazepam | 2 | 2017 | 136 | 0.300 |
Why?
|
Skin Ulcer | 1 | 2008 | 118 | 0.290 |
Why?
|
Quality of Life | 12 | 2023 | 12730 | 0.280 |
Why?
|
Epithelium | 1 | 2011 | 1680 | 0.280 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2015 | 2455 | 0.270 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2010 | 448 | 0.270 |
Why?
|
Diagnosis, Differential | 12 | 2021 | 12958 | 0.270 |
Why?
|
Radiation Injuries | 2 | 2017 | 1178 | 0.270 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2023 | 475 | 0.270 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2009 | 386 | 0.270 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2021 | 3497 | 0.260 |
Why?
|
Clobetasol | 2 | 2022 | 34 | 0.260 |
Why?
|
Dental Implantation, Endosseous | 1 | 2009 | 502 | 0.260 |
Why?
|
Anemia, Sickle Cell | 1 | 2013 | 1017 | 0.260 |
Why?
|
Cyclosporine | 1 | 2008 | 784 | 0.250 |
Why?
|
Salivary Proteins and Peptides | 1 | 2005 | 52 | 0.250 |
Why?
|
Leukoplakia | 2 | 2020 | 18 | 0.250 |
Why?
|
Ovariectomy | 2 | 2006 | 660 | 0.250 |
Why?
|
Treatment Outcome | 19 | 2022 | 62966 | 0.250 |
Why?
|
Young Adult | 14 | 2021 | 56350 | 0.250 |
Why?
|
Laryngoscopy | 1 | 2010 | 706 | 0.240 |
Why?
|
Triamcinolone Acetonide | 2 | 2019 | 101 | 0.240 |
Why?
|
Dyskeratosis Congenita | 1 | 2004 | 72 | 0.240 |
Why?
|
Trismus | 1 | 2023 | 33 | 0.240 |
Why?
|
Health Care Costs | 3 | 2022 | 3203 | 0.240 |
Why?
|
Protein Kinase Inhibitors | 3 | 2015 | 5522 | 0.240 |
Why?
|
Dental Care | 2 | 2019 | 262 | 0.240 |
Why?
|
Ambulatory Care | 1 | 2015 | 2706 | 0.230 |
Why?
|
Aged, 80 and over | 20 | 2021 | 57683 | 0.230 |
Why?
|
Adolescent | 21 | 2022 | 85649 | 0.230 |
Why?
|
Hematopoietic Stem Cells | 2 | 2020 | 3381 | 0.230 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2005 | 221 | 0.220 |
Why?
|
Minocycline | 1 | 2004 | 163 | 0.220 |
Why?
|
Monte Carlo Method | 2 | 2023 | 1254 | 0.220 |
Why?
|
Hyperpigmentation | 1 | 2004 | 112 | 0.220 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 2283 | 0.220 |
Why?
|
Cyclosporins | 1 | 2022 | 220 | 0.210 |
Why?
|
Leukemia, Eosinophilic, Acute | 1 | 2021 | 5 | 0.210 |
Why?
|
Pemphigus | 2 | 2017 | 103 | 0.210 |
Why?
|
Dentists | 2 | 2020 | 169 | 0.210 |
Why?
|
Intubation, Intratracheal | 1 | 2010 | 1357 | 0.200 |
Why?
|
Lymphoproliferative Disorders | 1 | 2005 | 525 | 0.200 |
Why?
|
Referral and Consultation | 1 | 2015 | 3527 | 0.200 |
Why?
|
Cytomegalovirus Infections | 1 | 2008 | 817 | 0.200 |
Why?
|
Hematologic Neoplasms | 4 | 2015 | 1820 | 0.200 |
Why?
|
Jaw | 3 | 2017 | 96 | 0.200 |
Why?
|
Mouthwashes | 3 | 2017 | 59 | 0.200 |
Why?
|
Severity of Illness Index | 7 | 2020 | 15530 | 0.200 |
Why?
|
Herpesvirus 1, Human | 1 | 2007 | 742 | 0.200 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2009 | 1379 | 0.200 |
Why?
|
Leukokeratosis, Hereditary Mucosal | 1 | 2020 | 1 | 0.190 |
Why?
|
Practice Guidelines as Topic | 7 | 2021 | 7276 | 0.190 |
Why?
|
Sarcoma, Myeloid | 1 | 2021 | 59 | 0.190 |
Why?
|
Anti-Inflammatory Agents | 4 | 2019 | 1788 | 0.190 |
Why?
|
Honey | 1 | 2020 | 11 | 0.180 |
Why?
|
Radiography, Dental, Digital | 2 | 2010 | 12 | 0.180 |
Why?
|
Facial Pain | 1 | 2021 | 124 | 0.180 |
Why?
|
Cohort Studies | 13 | 2023 | 40450 | 0.180 |
Why?
|
Behcet Syndrome | 1 | 2020 | 84 | 0.180 |
Why?
|
Wound Healing | 2 | 2010 | 2781 | 0.180 |
Why?
|
Maxillary Diseases | 2 | 2010 | 51 | 0.170 |
Why?
|
Osteosclerosis | 2 | 2010 | 39 | 0.170 |
Why?
|
Plants, Medicinal | 1 | 2020 | 167 | 0.170 |
Why?
|
Clinical Competence | 1 | 2015 | 4681 | 0.170 |
Why?
|
Steroids | 3 | 2022 | 931 | 0.170 |
Why?
|
Lacrimal Apparatus | 3 | 2006 | 224 | 0.170 |
Why?
|
Gingival Recession | 1 | 2022 | 189 | 0.170 |
Why?
|
Pain Measurement | 4 | 2010 | 3418 | 0.170 |
Why?
|
Prospective Studies | 12 | 2023 | 53187 | 0.170 |
Why?
|
Sex Characteristics | 4 | 2005 | 2585 | 0.170 |
Why?
|
Erythema | 3 | 2011 | 254 | 0.170 |
Why?
|
Cryotherapy | 2 | 2021 | 154 | 0.170 |
Why?
|
Fibroma | 1 | 2020 | 212 | 0.160 |
Why?
|
Heart Valves | 1 | 2020 | 291 | 0.160 |
Why?
|
Child | 15 | 2021 | 77478 | 0.160 |
Why?
|
Tooth Socket | 2 | 2010 | 124 | 0.160 |
Why?
|
Tooth Root | 1 | 2019 | 165 | 0.160 |
Why?
|
Radiometry | 1 | 2023 | 800 | 0.160 |
Why?
|
Prescriptions | 1 | 2021 | 387 | 0.160 |
Why?
|
Health Resources | 2 | 2016 | 911 | 0.160 |
Why?
|
Nasal Mucosa | 1 | 2020 | 373 | 0.150 |
Why?
|
Minerals | 1 | 2019 | 275 | 0.150 |
Why?
|
Lidocaine | 1 | 2021 | 542 | 0.150 |
Why?
|
Professional Role | 1 | 2020 | 306 | 0.150 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2013 | 780 | 0.150 |
Why?
|
Leukoplakia, Oral | 3 | 2024 | 73 | 0.150 |
Why?
|
Neurosurgical Procedures | 1 | 2008 | 2002 | 0.150 |
Why?
|
Precancerous Conditions | 1 | 2024 | 971 | 0.140 |
Why?
|
Mice, Inbred BALB C | 7 | 2006 | 6382 | 0.140 |
Why?
|
Canada | 2 | 2020 | 2061 | 0.140 |
Why?
|
Child, Preschool | 8 | 2016 | 40955 | 0.140 |
Why?
|
Graft Rejection | 3 | 2020 | 4393 | 0.140 |
Why?
|
Probiotics | 1 | 2020 | 351 | 0.140 |
Why?
|
Glutamine | 1 | 2019 | 574 | 0.140 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 1 | 2017 | 123 | 0.140 |
Why?
|
Hyperbaric Oxygenation | 1 | 2017 | 163 | 0.140 |
Why?
|
Brazil | 1 | 2020 | 1263 | 0.140 |
Why?
|
Injections, Intravenous | 2 | 2008 | 1420 | 0.140 |
Why?
|
Recurrence | 3 | 2021 | 8333 | 0.130 |
Why?
|
Dental Pulp | 1 | 2016 | 82 | 0.130 |
Why?
|
Dental Occlusion | 1 | 2015 | 54 | 0.130 |
Why?
|
Boston | 3 | 2019 | 9305 | 0.130 |
Why?
|
United States | 11 | 2020 | 69693 | 0.130 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2006 | 3920 | 0.130 |
Why?
|
Adenine | 1 | 2020 | 936 | 0.120 |
Why?
|
Tooth Diseases | 1 | 2015 | 77 | 0.120 |
Why?
|
Psychometrics | 3 | 2021 | 2999 | 0.120 |
Why?
|
Bone Marrow | 2 | 2023 | 2941 | 0.120 |
Why?
|
Face | 1 | 2020 | 993 | 0.120 |
Why?
|
Nursing Methodology Research | 2 | 2011 | 67 | 0.120 |
Why?
|
Petrolatum | 1 | 2013 | 8 | 0.120 |
Why?
|
Photomicrography | 1 | 2013 | 74 | 0.120 |
Why?
|
Keratolytic Agents | 1 | 2013 | 31 | 0.120 |
Why?
|
Emollients | 1 | 2013 | 33 | 0.120 |
Why?
|
Immunomodulation | 1 | 2018 | 540 | 0.120 |
Why?
|
Pharyngeal Diseases | 1 | 2015 | 132 | 0.120 |
Why?
|
Mupirocin | 1 | 2013 | 56 | 0.120 |
Why?
|
Skin | 1 | 2007 | 4353 | 0.110 |
Why?
|
Radiotherapy | 4 | 2021 | 1525 | 0.110 |
Why?
|
Osteoporosis | 2 | 2013 | 1581 | 0.110 |
Why?
|
Clinical Trials, Phase I as Topic | 2 | 2011 | 319 | 0.110 |
Why?
|
Sensation | 1 | 2015 | 337 | 0.110 |
Why?
|
Forkhead Transcription Factors | 2 | 2018 | 1613 | 0.110 |
Why?
|
Heart Valve Diseases | 1 | 2020 | 1067 | 0.110 |
Why?
|
Biopsy | 3 | 2021 | 6756 | 0.110 |
Why?
|
Urban Population | 1 | 2020 | 2018 | 0.110 |
Why?
|
Clinical Trials as Topic | 3 | 2015 | 7901 | 0.110 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2008 | 1769 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1575 | 0.100 |
Why?
|
Phototherapy | 1 | 2015 | 377 | 0.100 |
Why?
|
Piperidines | 1 | 2020 | 1602 | 0.100 |
Why?
|
Anti-Bacterial Agents | 2 | 2013 | 7153 | 0.100 |
Why?
|
Administration, Oral | 2 | 2017 | 3913 | 0.100 |
Why?
|
Placebos | 2 | 2006 | 1677 | 0.100 |
Why?
|
Preoperative Care | 1 | 2020 | 2245 | 0.100 |
Why?
|
Registries | 4 | 2023 | 8077 | 0.100 |
Why?
|
Patient Education as Topic | 3 | 2015 | 2275 | 0.100 |
Why?
|
Xanthomatosis | 1 | 2011 | 32 | 0.100 |
Why?
|
Bone Marrow Transplantation | 3 | 2015 | 2763 | 0.100 |
Why?
|
beta-Thalassemia | 1 | 2013 | 225 | 0.100 |
Why?
|
Surgical Wound Infection | 1 | 2020 | 1538 | 0.100 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2017 | 806 | 0.100 |
Why?
|
Tretinoin | 1 | 2013 | 516 | 0.090 |
Why?
|
Vitamins | 1 | 2019 | 1608 | 0.090 |
Why?
|
Oroantral Fistula | 1 | 2010 | 8 | 0.090 |
Why?
|
Dry Socket | 1 | 2010 | 7 | 0.090 |
Why?
|
Acute Disease | 2 | 2014 | 7141 | 0.090 |
Why?
|
RNA, Messenger | 7 | 2006 | 13029 | 0.090 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2014 | 395 | 0.090 |
Why?
|
Lichenoid Eruptions | 1 | 2009 | 14 | 0.090 |
Why?
|
Rural Population | 1 | 2020 | 2207 | 0.090 |
Why?
|
Dermatologic Agents | 1 | 2013 | 274 | 0.090 |
Why?
|
Herpesviridae Infections | 1 | 2011 | 277 | 0.090 |
Why?
|
Survival Rate | 2 | 2021 | 12773 | 0.090 |
Why?
|
Pain | 4 | 2021 | 4961 | 0.090 |
Why?
|
Multiple Myeloma | 4 | 2008 | 5169 | 0.090 |
Why?
|
Intestinal Diseases | 1 | 2015 | 531 | 0.090 |
Why?
|
Placebo Effect | 1 | 2013 | 502 | 0.090 |
Why?
|
Chest Tubes | 1 | 2010 | 150 | 0.090 |
Why?
|
Dental Fistula | 1 | 2009 | 13 | 0.090 |
Why?
|
Immunotherapy | 2 | 2024 | 4414 | 0.090 |
Why?
|
Mucocele | 1 | 2009 | 49 | 0.090 |
Why?
|
Streptococcal Infections | 1 | 2014 | 637 | 0.090 |
Why?
|
Medical History Taking | 1 | 2013 | 783 | 0.090 |
Why?
|
Orchiectomy | 3 | 2005 | 466 | 0.080 |
Why?
|
Nonprescription Drugs | 1 | 2010 | 116 | 0.080 |
Why?
|
Longitudinal Studies | 3 | 2017 | 13921 | 0.080 |
Why?
|
Alendronate | 1 | 2010 | 171 | 0.080 |
Why?
|
Dental Arch | 1 | 2008 | 38 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2014 | 1184 | 0.080 |
Why?
|
Mandibular Prosthesis Implantation | 1 | 2008 | 3 | 0.080 |
Why?
|
Dental Restoration, Permanent | 1 | 2009 | 127 | 0.080 |
Why?
|
Nursing Assessment | 1 | 2008 | 107 | 0.080 |
Why?
|
Palatal Neoplasms | 1 | 2008 | 35 | 0.080 |
Why?
|
Mycoses | 1 | 2011 | 376 | 0.080 |
Why?
|
Periapical Abscess | 1 | 2008 | 16 | 0.080 |
Why?
|
Parotitis | 1 | 2008 | 29 | 0.080 |
Why?
|
Drug Costs | 1 | 2016 | 1104 | 0.080 |
Why?
|
Educational Measurement | 1 | 2015 | 1206 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9185 | 0.080 |
Why?
|
Lip Diseases | 1 | 2007 | 18 | 0.080 |
Why?
|
Skin Diseases | 2 | 2015 | 1065 | 0.080 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2008 | 88 | 0.080 |
Why?
|
Anti-Infective Agents, Local | 1 | 2010 | 250 | 0.080 |
Why?
|
Ganciclovir | 1 | 2008 | 259 | 0.080 |
Why?
|
Pediatric Nursing | 1 | 2008 | 103 | 0.080 |
Why?
|
Dental Prosthesis, Implant-Supported | 1 | 2009 | 215 | 0.080 |
Why?
|
Herpesviridae | 1 | 2008 | 109 | 0.070 |
Why?
|
Factitious Disorders | 1 | 2007 | 41 | 0.070 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11363 | 0.070 |
Why?
|
Physical Examination | 1 | 2013 | 1239 | 0.070 |
Why?
|
Time Factors | 5 | 2020 | 40054 | 0.070 |
Why?
|
Laser Therapy | 1 | 2013 | 1071 | 0.070 |
Why?
|
Drinking | 1 | 2008 | 197 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2021 | 19862 | 0.070 |
Why?
|
Facial Dermatoses | 1 | 2007 | 87 | 0.070 |
Why?
|
Osteolysis | 1 | 2008 | 270 | 0.070 |
Why?
|
Ancillary Services, Hospital | 1 | 2006 | 23 | 0.070 |
Why?
|
Clindamycin | 1 | 2006 | 139 | 0.070 |
Why?
|
Liver Diseases | 1 | 2015 | 1252 | 0.070 |
Why?
|
Fatal Outcome | 2 | 2008 | 1849 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3215 | 0.070 |
Why?
|
Patient Selection | 2 | 2017 | 4214 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2016 | 5062 | 0.070 |
Why?
|
RNA | 2 | 2006 | 2747 | 0.070 |
Why?
|
Observer Variation | 2 | 2009 | 2593 | 0.070 |
Why?
|
Meibomian Glands | 1 | 2005 | 85 | 0.070 |
Why?
|
Virus Diseases | 1 | 2011 | 710 | 0.070 |
Why?
|
Chlorhexidine | 1 | 2006 | 162 | 0.070 |
Why?
|
Cardiac Surgical Procedures | 1 | 2020 | 3526 | 0.060 |
Why?
|
Medical Staff, Hospital | 1 | 2009 | 603 | 0.060 |
Why?
|
Eye Proteins | 2 | 2006 | 644 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3070 | 0.060 |
Why?
|
Interleukin-2 | 1 | 2011 | 1887 | 0.060 |
Why?
|
Pyrroles | 1 | 2011 | 1143 | 0.060 |
Why?
|
Drug Resistance | 2 | 2011 | 1608 | 0.060 |
Why?
|
Fibrin | 1 | 2007 | 506 | 0.060 |
Why?
|
Palate, Hard | 1 | 2004 | 57 | 0.060 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4929 | 0.060 |
Why?
|
Risk Factors | 7 | 2023 | 72145 | 0.060 |
Why?
|
Imidazoles | 1 | 2010 | 1205 | 0.060 |
Why?
|
Incidence | 3 | 2022 | 20928 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 1999 | 3695 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4553 | 0.060 |
Why?
|
Drug Approval | 1 | 2010 | 740 | 0.060 |
Why?
|
Melanosis | 1 | 2004 | 78 | 0.060 |
Why?
|
Macrophages | 1 | 2018 | 5655 | 0.060 |
Why?
|
Rare Diseases | 1 | 2008 | 554 | 0.060 |
Why?
|
Bacterial Infections | 1 | 2011 | 1389 | 0.060 |
Why?
|
Tongue Neoplasms | 1 | 2004 | 179 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5304 | 0.050 |
Why?
|
Statistics as Topic | 1 | 2009 | 2372 | 0.050 |
Why?
|
Pilot Projects | 1 | 2016 | 8297 | 0.050 |
Why?
|
Fluocinonide | 1 | 2022 | 9 | 0.050 |
Why?
|
Periodontitis | 1 | 2008 | 553 | 0.050 |
Why?
|
Indoles | 1 | 2011 | 1834 | 0.050 |
Why?
|
Anemia, Aplastic | 1 | 2004 | 226 | 0.050 |
Why?
|
Tooth Cervix | 1 | 2022 | 16 | 0.050 |
Why?
|
Hodgkin Disease | 1 | 2010 | 1413 | 0.050 |
Why?
|
Triamcinolone | 1 | 2022 | 68 | 0.050 |
Why?
|
Up-Regulation | 3 | 2005 | 4211 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2010 | 1581 | 0.050 |
Why?
|
Genomics | 1 | 2018 | 5692 | 0.050 |
Why?
|
Gastrointestinal Agents | 1 | 2007 | 494 | 0.050 |
Why?
|
Syndrome | 1 | 2008 | 3248 | 0.050 |
Why?
|
Curriculum | 1 | 2015 | 3589 | 0.050 |
Why?
|
Self-Injurious Behavior | 1 | 2007 | 462 | 0.050 |
Why?
|
Fluorides | 1 | 2022 | 126 | 0.050 |
Why?
|
Survival Analysis | 2 | 2018 | 10248 | 0.050 |
Why?
|
Data Collection | 1 | 2011 | 3339 | 0.050 |
Why?
|
Causality | 1 | 2008 | 1265 | 0.050 |
Why?
|
Progesterone | 1 | 2006 | 773 | 0.050 |
Why?
|
Down-Regulation | 2 | 2005 | 3001 | 0.050 |
Why?
|
Parotid Gland | 1 | 2022 | 168 | 0.050 |
Why?
|
Epidemiologic Factors | 1 | 2020 | 30 | 0.050 |
Why?
|
Dental Implants | 1 | 2009 | 749 | 0.050 |
Why?
|
Oropharynx | 1 | 2021 | 127 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6608 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2015 | 9941 | 0.050 |
Why?
|
Chewing Gum | 1 | 2020 | 41 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10163 | 0.050 |
Why?
|
Accidental Falls | 1 | 2008 | 1057 | 0.050 |
Why?
|
Pain, Postoperative | 1 | 2010 | 1638 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8425 | 0.040 |
Why?
|
Animals | 9 | 2020 | 168561 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2906 | 0.040 |
Why?
|
Community Medicine | 1 | 2019 | 25 | 0.040 |
Why?
|
Crohn Disease | 2 | 2015 | 2301 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 6483 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2007 | 9274 | 0.040 |
Why?
|
Anti-Infective Agents | 1 | 2006 | 971 | 0.040 |
Why?
|
Radiography | 1 | 2010 | 7010 | 0.040 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 768 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2005 | 1402 | 0.040 |
Why?
|
Injections, Intralesional | 1 | 2019 | 276 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9639 | 0.040 |
Why?
|
Infection Control | 1 | 2006 | 962 | 0.040 |
Why?
|
Mice | 7 | 2006 | 81045 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2007 | 3471 | 0.040 |
Why?
|
Estradiol | 1 | 2006 | 2021 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2011 | 2986 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2008 | 2940 | 0.040 |
Why?
|
Androgens | 1 | 2005 | 1271 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5462 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 11472 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 13853 | 0.040 |
Why?
|
DMF Index | 1 | 2017 | 90 | 0.040 |
Why?
|
Eosinophilia | 1 | 2021 | 531 | 0.040 |
Why?
|
Solutions | 1 | 2017 | 426 | 0.040 |
Why?
|
Tooth Calcification | 1 | 2016 | 8 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 4029 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2021 | 1758 | 0.030 |
Why?
|
Gene Expression Profiling | 3 | 2008 | 9410 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 6171 | 0.030 |
Why?
|
Periodontal Abscess | 1 | 2015 | 4 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2011 | 3123 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2008 | 2522 | 0.030 |
Why?
|
Consensus | 2 | 2015 | 2935 | 0.030 |
Why?
|
Analgesia | 1 | 2020 | 459 | 0.030 |
Why?
|
Erythema Multiforme | 1 | 2015 | 31 | 0.030 |
Why?
|
Truth Disclosure | 1 | 2019 | 435 | 0.030 |
Why?
|
SEER Program | 1 | 2020 | 1507 | 0.030 |
Why?
|
Consensus Development Conferences, NIH as Topic | 1 | 2014 | 28 | 0.030 |
Why?
|
Feeding Behavior | 1 | 2008 | 3187 | 0.030 |
Why?
|
Sex Distribution | 1 | 2020 | 2295 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1905 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3839 | 0.030 |
Why?
|
Age Distribution | 1 | 2020 | 2900 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 553 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4229 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2020 | 1118 | 0.030 |
Why?
|
Dioxygenases | 1 | 2016 | 316 | 0.030 |
Why?
|
Focus Groups | 2 | 2008 | 1320 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 4751 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2016 | 905 | 0.030 |
Why?
|
Vascular Grafting | 1 | 2015 | 142 | 0.030 |
Why?
|
Antilymphocyte Serum | 1 | 2015 | 491 | 0.030 |
Why?
|
Mycophenolic Acid | 1 | 2015 | 343 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4187 | 0.030 |
Why?
|
Patient Preference | 1 | 2019 | 886 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1255 | 0.030 |
Why?
|
Scleroderma, Systemic | 1 | 2016 | 313 | 0.030 |
Why?
|
Asthenia | 1 | 2011 | 16 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2020 | 6365 | 0.030 |
Why?
|
Income | 1 | 2020 | 1904 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3564 | 0.020 |
Why?
|
Skin Neoplasms | 2 | 2016 | 5662 | 0.020 |
Why?
|
Central Nervous System Stimulants | 1 | 2020 | 1148 | 0.020 |
Why?
|
Foam Cells | 1 | 2011 | 71 | 0.020 |
Why?
|
Photosensitizing Agents | 1 | 2015 | 602 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13256 | 0.020 |
Why?
|
Observation | 1 | 2011 | 312 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 2003 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 1999 | 1335 | 0.020 |
Why?
|
Infant | 2 | 2015 | 35070 | 0.020 |
Why?
|
Nursing Evaluation Research | 1 | 2008 | 26 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3585 | 0.020 |
Why?
|
Dental Amalgam | 1 | 2009 | 67 | 0.020 |
Why?
|
Necrosis | 1 | 2013 | 1643 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2011 | 10943 | 0.020 |
Why?
|
Periodontal Pocket | 1 | 2009 | 166 | 0.020 |
Why?
|
Sialometaplasia, Necrotizing | 1 | 2008 | 6 | 0.020 |
Why?
|
Documentation | 1 | 2015 | 865 | 0.020 |
Why?
|
Dental Materials | 1 | 2009 | 108 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2017 | 1927 | 0.020 |
Why?
|
Nurse-Patient Relations | 1 | 2008 | 101 | 0.020 |
Why?
|
Patient Compliance | 1 | 2019 | 2680 | 0.020 |
Why?
|
Granuloma, Pyogenic | 1 | 2008 | 48 | 0.020 |
Why?
|
Palate | 1 | 2008 | 123 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12344 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2011 | 1583 | 0.020 |
Why?
|
Tooth Extraction | 1 | 2009 | 222 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2005 | 21719 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12017 | 0.020 |
Why?
|
Standard of Care | 1 | 2011 | 562 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2019 | 3294 | 0.020 |
Why?
|
Exanthema | 1 | 2011 | 488 | 0.020 |
Why?
|
Hypothyroidism | 1 | 2011 | 659 | 0.020 |
Why?
|
Photography, Dental | 1 | 2005 | 21 | 0.020 |
Why?
|
Communication | 1 | 2019 | 3728 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2008 | 11039 | 0.020 |
Why?
|
Parents | 2 | 2009 | 3387 | 0.020 |
Why?
|
Parent-Child Relations | 1 | 2009 | 747 | 0.020 |
Why?
|
Cancer Care Facilities | 1 | 2008 | 401 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2008 | 20086 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10472 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2008 | 575 | 0.020 |
Why?
|
Hyperplasia | 1 | 2007 | 1183 | 0.010 |
Why?
|
Disease Management | 1 | 2015 | 2450 | 0.010 |
Why?
|
Diarrhea | 1 | 2011 | 1343 | 0.010 |
Why?
|
Fatigue | 1 | 2011 | 1526 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2016 | 4455 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11470 | 0.010 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2006 | 694 | 0.010 |
Why?
|
Inflammation | 2 | 2016 | 10578 | 0.010 |
Why?
|
Needs Assessment | 1 | 2008 | 1146 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2009 | 2876 | 0.010 |
Why?
|
Age Factors | 2 | 2009 | 18355 | 0.010 |
Why?
|
Prostheses and Implants | 1 | 2009 | 1385 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2008 | 1503 | 0.010 |
Why?
|
Prednisone | 1 | 2006 | 1567 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2008 | 20774 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5979 | 0.010 |
Why?
|
Osteogenesis | 1 | 2008 | 1299 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8662 | 0.010 |
Why?
|
Attitude to Health | 1 | 2009 | 2051 | 0.010 |
Why?
|
Drug Combinations | 1 | 2006 | 1961 | 0.010 |
Why?
|
Musculoskeletal Diseases | 1 | 2006 | 581 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29010 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2008 | 2013 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2885 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2006 | 1269 | 0.010 |
Why?
|
Lung Transplantation | 1 | 2007 | 1155 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2015 | 4440 | 0.010 |
Why?
|
Patient Care Team | 1 | 2008 | 2527 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10392 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16331 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2009 | 3014 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39004 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14720 | 0.010 |
Why?
|
Hospitalization | 1 | 2014 | 10232 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 29717 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2006 | 4664 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6259 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2005 | 7721 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2005 | 21821 | 0.000 |
Why?
|
Risk Assessment | 1 | 2008 | 23320 | 0.000 |
Why?
|